An interview with Saturn3 Co-coordinator Prof. Dr. Andreas Trumpp (German Cancer Research Center (DKFZ), Head of Department “Stem Cells and Cancer”, Managing Director of the Stem Cell Institute “HI-STEM gGmbH”) Published in the February 2025 edition of the breast cancer magazine Mamma Mia!: https://mammamia-online.de/shop/brustkrebsmagazin-digital-02-2025 You’re also welcome to take a look at the free guide… Continue reading Therapy resistance, recurrence and metastasis: How can resistance be overcome?
Author: Tassilo Steinmann
Multimodal survival prediction in advanced pancreatic cancer using machine learning
Keyl J, Kasper S, Wiesweg M, et al. Multimodal survival prediction in advanced pancreatic cancer using machine learning (PMID: 35988455). ESMO Open. Epub 2022.
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma
Heid I, Münch C, Karakaya S, et al. Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma (PMID: 36494842). Cancer Metab. 2022.
HAPLN1 potentiates peritoneal metastasis in pancreatic cancer
Wiedmann L, De Angelis Rigotti F, Vaquero-Siguero N, et al. HAPLN1 potentiates peritoneal metastasis in pancreatic cancer (PMID: 37095087). Nat Commun. 2023.
Enhancing sensitivity and versatility of Tn5-based single cell omics
Seufert I, Sant P, Bauer K, et al. Enhancing sensitivity and versatility of Tn5-based single cell omics. bioRxiv. 2023.
Approaches for single-cell RNA sequencing across tissues and cell types
Sant P, Rippe K and Mallm JP. Approaches for single-cell RNA sequencing across tissues and cell types (PMID: 37062951). Transcription. 2023.
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer
Saini M, Schmidleitner L, Moreno HD, et al. Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer (PMID: 37257449). Cell Rep. Epub 2023.
Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer
Reissig TM, Tzianopoulos I, Liffers ST, et al. Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer (PMID: 37148593). ESMO Open. Epub 2023.
Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype
Liffers ST, Godfrey L, Frohn L, et al. Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype (PMID: 35944927). Gut. 2023.
In-vitro model to mimic T cell subset change in human PDAC organoid co-culture
Knoblauch M, Ma T, Beirith I, et al. In-vitro model to mimic T cell subset change in human PDAC organoid co-culture (PMID: 37470855). J Cancer Res Clin Oncol. Epub 2023.
